Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by HuntNGatheron Jun 13, 2014 4:13pm
324 Views
Post# 22659158

Until OutHouse gets this figured out... I will post it here

Until OutHouse gets this figured out... I will post it herePlease note that last post with the Gold Leaf award. Dr. Stiller's rather giddy words are quite encouraging in my view. Today may have dropped 8% on minimal volume but the fact remains that the raise that was pulled off had major health funds behind it so this is not just hot air. CD47 is pretty exciting stuff and may be the golden ticket. Or, because this is biotech...it may turn to dust. But at least we have a shot. Come on Stockhouse... sort out your boards and put a TR board up. HnG
Bullboard Posts